These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The effect of intraperitoneal administration of leptin on short-term food intake in rats. Patel JD; Ebenezer IS Eur J Pharmacol; 2008 Feb; 580(1-2):143-52. PubMed ID: 18031736 [TBL] [Abstract][Full Text] [Related]
27. Leptin analog antagonizes leptin effects on food intake and body weight but mimics leptin-induced vagal afferent activation. Peters JH; Simasko SM; Ritter RC Endocrinology; 2007 Jun; 148(6):2878-85. PubMed ID: 17363463 [TBL] [Abstract][Full Text] [Related]
28. Metabolic responses to intracerebroventricular leptin and restricted feeding. Wang T; Hartzell DL; Rose BS; Flatt WP; Hulsey MG; Menon NK; Makula RA; Baile CA Physiol Behav; 1999 Jan 1-15; 65(4-5):839-48. PubMed ID: 10073490 [TBL] [Abstract][Full Text] [Related]
29. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Bhavsar S; Watkins J; Young A Physiol Behav; 1998 Jun; 64(4):557-61. PubMed ID: 9761232 [TBL] [Abstract][Full Text] [Related]
30. Effects of central or peripheral leptin administration on norepinephrine turnover in defined fat depots. Penn DM; Jordan LC; Kelso EW; Davenport JE; Harris RB Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1613-21. PubMed ID: 16840651 [TBL] [Abstract][Full Text] [Related]
31. Gastroprotection and control of food intake by leptin. Comparison with cholecystokinin and prostaglandins. Konturek PC; Konturek SJ; Brzozowski T; Hahn EG J Physiol Pharmacol; 1999 Mar; 50(1):39-48. PubMed ID: 10210153 [TBL] [Abstract][Full Text] [Related]
32. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Calapai G; Corica F; Allegra A; Corsonello A; Sautebin L; De Gregorio T; Di Rosa M; Costantino G; Buemi M; Caputi AP Br J Pharmacol; 1998 Oct; 125(4):798-802. PubMed ID: 9831917 [TBL] [Abstract][Full Text] [Related]
33. Rapid development of tolerance to the behavioural actions of cholecystokinin. Crawley JN; Beinfeld MC Nature; 1983 Apr; 302(5910):703-6. PubMed ID: 6300693 [TBL] [Abstract][Full Text] [Related]
34. Lack of tolerance development with long-term administration of PEGylated cholecystokinin. Verbaeys I; León-Tamariz F; Buyse J; Decuypere E; Pottel H; Cokelaere M Peptides; 2009 Apr; 30(4):699-704. PubMed ID: 19084041 [TBL] [Abstract][Full Text] [Related]
35. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents. Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356 [TBL] [Abstract][Full Text] [Related]
36. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms. Kanoski SE; Ong ZY; Fortin SM; Schlessinger ES; Grill HJ Diabetes Obes Metab; 2015 Mar; 17(3):285-93. PubMed ID: 25475828 [TBL] [Abstract][Full Text] [Related]
37. A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin. Cano V; Merino B; Ezquerra L; Somoza B; Ruiz-Gayo M Br J Pharmacol; 2008 Jul; 154(5):1009-15. PubMed ID: 18587446 [TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Glatzle J; Raybould HE; Kueper MA; Reeve JR; Zittel TT Nutr Neurosci; 2008 Apr; 11(2):69-74. PubMed ID: 18510806 [TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Barrachina MD; Martínez V; Wang L; Wei JY; Taché Y Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10455-60. PubMed ID: 9294232 [TBL] [Abstract][Full Text] [Related]
40. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Ellacott KL; Lawrence CB; Rothwell NJ; Luckman SM Endocrinology; 2002 Feb; 143(2):368-74. PubMed ID: 11796488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]